KYLE HIRSCH: Open Payments
NPI 1447022827 · VICTORVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,028 in 45 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $1,365 · 2025 $1,028
Food & beverage: $954Education: $74
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 11 | $294 |
| LEO Pharma Inc. | 13 | $236 |
| Regeneron Healthcare Solutions, Inc. | 2 | $113 |
| Arcutis Biotherapeutics, Inc. | 3 | $73 |
| Amgen Inc. | 4 | $68 |
| Galderma Laboratories, L.P. | 3 | $60 |
| GENZYME CORPORATION | 1 | $45 |
| Organon LLC | 2 | $35 |
| Janssen Biotech, Inc. | 2 | $34 |
| ABBVIE INC. | 2 | $29 |
Products named: Bimzelx, ADBRY, DUPIXENT, Zoryve, Otezla, NEMLUVIO, VTAMA, TREMFYA.
Industry payments across CA — which companies pay providers there.
